NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT00499291 2023-05-25Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsEastern Cooperative Oncology GroupPhase NA Withdrawn
NCT00028535 2013-06-04Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed18 enrolled